Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Cytokinetics Inc. buy Raymond James

Cytokinetics Inc.
Start price
€45.60
23.05.24 / 50%
Target price
€64.60
23.05.25
Performance (%)
-41.23%
End price
€26.80
24.05.25
Summary
This prediction ended on 24.05.25 with a price of €26.80. The BUY prediction by Raymond_James for Cytokinetics Inc. performed very badly with a performance of -41.23%. Raymond_James has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cytokinetics Inc. -3.436% -3.436% 93.012%
iShares Core DAX® 0.437% 5.897% 8.047%
iShares Nasdaq 100 1.057% 0.920% 28.466%
iShares Nikkei 225® 1.769% 1.228% 47.574%
iShares S&P 500 0.368% 1.920% 23.200%

Comments by Raymond_James for this prediction

In the thread Discuss Cytokinetics Inc.
Prediction Buy
Perf. (%) -41.23%
Target price 64.596
Change
Ends at 23.05.25

Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Raymond James from $92.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for CYTK provided by MarketBeat

Raymond James 
0
Report Share
23.05.24
In the thread Trading Cytokinetics Inc.
Prediction Buy
Perf. (%) -41.23%
Target price 64.596
Change
Ends at 23.05.25

Die von Raymond_James gewählte maximale Laufzeit wurde überschritten

Raymond James 
0
Report Share
24.05.25

Stopped prediction by Raymond_James for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€76.00
28.12.23
€83.06
28.12.24
-41.05%
29.12.24

Raymond James 
28.12.23 50%